BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 23395248)

  • 1. Global economic burden of Chagas disease: a computational simulation model.
    Lee BY; Bacon KM; Bottazzi ME; Hotez PJ
    Lancet Infect Dis; 2013 Apr; 13(4):342-8. PubMed ID: 23395248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
    Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
    Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Economic and Health Burden of Human Hookworm Infection.
    Bartsch SM; Hotez PJ; Asti L; Zapf KM; Bottazzi ME; Diemert DJ; Lee BY
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004922. PubMed ID: 27607360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Economic Burden of Norovirus Gastroenteritis.
    Bartsch SM; Lopman BA; Ozawa S; Hall AJ; Lee BY
    PLoS One; 2016; 11(4):e0151219. PubMed ID: 27115736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of Chagas disease in Colombia in 2017: A social perspective.
    Olivera MJ; Buitrago G
    Int J Infect Dis; 2020 Feb; 91():196-201. PubMed ID: 31770619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of physical inactivity: a global analysis of major non-communicable diseases.
    Ding D; Lawson KD; Kolbe-Alexander TL; Finkelstein EA; Katzmarzyk PT; van Mechelen W; Pratt M;
    Lancet; 2016 Sep; 388(10051):1311-24. PubMed ID: 27475266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting Long-term Health and Economic Burden of COPD in the United States.
    Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
    Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Kidney Disease Collaboration
    Lancet; 2020 Feb; 395(10225):709-733. PubMed ID: 32061315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
    Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
    Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):709-722. PubMed ID: 34329626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9063):1436-42. PubMed ID: 9164317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years.
    Troeger C; Colombara DV; Rao PC; Khalil IA; Brown A; Brewer TG; Guerrant RL; Houpt ER; Kotloff KL; Misra K; Petri WA; Platts-Mills J; Riddle MS; Swartz SJ; Forouzanfar MH; Reiner RC; Hay SI; Mokdad AH
    Lancet Glob Health; 2018 Mar; 6(3):e255-e269. PubMed ID: 29433665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.
    Degenhardt L; Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Hall WD; Freedman G; Burstein R; Johns N; Engell RE; Flaxman A; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1564-74. PubMed ID: 23993281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.
    Lee BY; Bacon KM; Connor DL; Willig AM; Bailey RR
    PLoS Negl Trop Dis; 2010 Dec; 4(12):e916. PubMed ID: 21179503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis.
    Requena-Méndez A; Bussion S; Aldasoro E; Jackson Y; Angheben A; Moore D; Pinazo MJ; Gascón J; Muñoz J; Sicuri E
    Lancet Glob Health; 2017 Apr; 5(4):e439-e447. PubMed ID: 28256340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.